SecBot SecBot
SECBOTREPLAY Home › Report › MLYS

MLYS · Jon Congleton, an officer of Mineralys Therapeutics, filed a Form 144…

Mineralys Therapeutics, Inc. · 144 filed Apr 13, 2026 at 16:22 ET

At the news

NEUTRALIMPACT 3/10

144 filed Apr 13, 2026 at 16:22 ET

Jon Congleton, an officer of Mineralys Therapeutics, filed a Form 144 to notify intent to sell 15,730 shares of common stock, which vested on April 10, 2026, as part of a restricted share unit award. The sale is planned through Merrill Lynch on Nasdaq.

  • Jon Congleton, an officer, intends to sell 15,730 shares of MLYS common stock.
  • Shares were acquired on April 10, 2026, due to vesting of restricted share units granted under the company's equity compensation plan.
  • The filing was submitted on April 13, 2026, with Merrill Lynch listed as the broker.
  • No sales have occurred yet; this is a notice of proposed sale.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access